Package 50742-402-05

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50742-402-05
Digits Only 5074240205
Product NDC 50742-402
Product ID 50742-402_3c841594-8a93-4728-b184-0f4bfac73390
Description

1 VIAL, GLASS in 1 CARTON (50742-402-05) / 5 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2017-06-05
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3c841594-8a93-4728-b184-0f4bfac73390", "openfda": {"upc": ["0350742401024", "0350742402052"], "unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324"], "spl_set_id": ["d04f2471-3085-4fc8-a657-bb3918d48e6e"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (50742-402-05)  / 5 mL in 1 VIAL, GLASS", "package_ndc": "50742-402-05", "marketing_start_date": "20170605"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "50742-402_3c841594-8a93-4728-b184-0f4bfac73390", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "50742-402", "generic_name": "Irinotecan Hydrochloride", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "100 mg/5mL"}], "application_number": "ANDA206935", "marketing_category": "ANDA", "marketing_start_date": "20170605", "listing_expiration_date": "20261231"}